Recently, the consistent surface overexpression of the cation independent mannose-6-phosphate/insulin-like growth factor-2 receptor (IGF2R) has been reported across a panel of osteosarcoma tumors, including both standard and patient-derived xenograft lines7. Here, IGF2R is linked to osteosarcoma.